Items tagged with Drug-resistant TB
Global TB CAB responds to new bedaquiline price (post with simple image)
The TB CAB reiterates its request for Johnson & Johnson to commit to a global price for bedaquiline that is no higher than US$32 per month.
WHO announces landmark changes in MDR-TB treatment regimens (post with simple image)
Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant TB (MDR-TB) are expected.
The TB CAB and TAG welcome WHO recommendation of injectable-free regimens for the treatment of RR/MDR-TB (post with simple image)
The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.
Urgent need to register essential medicines for the treatment and prevention of TB in South Africa (post with simple image)
Advocates request that the South African Health Products Regulatory Authority expedite registration of essential medicines for the treatment and prevention of TB in South Africa.
Médecins Sans Frontières calls for affordable access to critical TB drug bedaquiline (post with simple image)
Médecins Sans Frontières to Johnson & Johnson: We need affordable and sustainable supply of bedaquiline.
An Activist’s Guide to Bedaquiline (Sirturo) (post with simple image)
The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.
Advocates call on Otsuka to reduce the price of delamanid (post with simple image)
Advocates ask Otsuka to lower the price of delamanid in line with Médecins sans Frontières target regimen cost of $500.
Médecins Sans Frontières calls on Johnson & Johnson to cut key TB drug price in half (post with simple image)
Warns high prices of TB drugs restrict people's access to best drug-resistant TB treatment.
Activists urge National TB Programs and treatment providers to discontinue use of harmful injectable agents in TB treatment (post with simple image)
In a symbolic display, activists invited conference participants to discard the injectable agents and commit to rapidly scaling up access to safer, more effective medicine.
Activists interrupt TB conference opening ceremony to call on J&J to cut price of TB drug in half, to one dollar per day (post with simple image)
Activists demand that Johnson & Johnson cut the price of bedaquiline in half, to no higher than $1 per day—$32 per person per month—double the price that researchers estimate bedaquiline could be sold for a profit.
Page 88 of 92 · Total posts: 0←First 87 88 89 Last→